Sugammadex, neostigmine and postoperative pulmonary complications: an international randomised feasibility and pilot trial.

Kate LeslieMatthew T V ChanJai N DarvallAnurika P De SilvaSabine BraatNancy J DevlinPhilip J PeytonJade RadnorCarmen K M LamSofia SidiropoulosDavid A Story

Published in: Pilot and feasibility studies (2021)

Prospectively registered at the Australian and New Zealand Clinical Trials Registry ( ACTRN12620001313921 ) on December 7, 2020. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380645&isReview=true .

Keyphrases

clinical trial
phase ii
phase iii
open label
study protocol
pulmonary hypertension
double blind
patients undergoing
sensitive detection
risk factors
placebo controlled
randomized controlled trial
quantum dots